Comparing the ratios of MSI2 levels between the three CXCR4/CD5 fractions showed that the PF contains 22% more MSI2 than the IF, and the IF 13% more than the RF in all 25 CLL cases studied (Fig. S1D). The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.